Evidence map›Paper›PMID 25893665›Full record

ArticlePloS one2015

Identification of Outer Membrane and Exoproteins of Carbapenem-Resistant Multilocus Sequence Type 258 Klebsiella pneumoniae.

Amanda J Brinkworth, Carl H Hammer, L Renee Olano, Scott D Kobayashi, Liang Chen, Barry N Kreiswirth, Frank R DeLeo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Variable progressive behavior ofFrontiers in immunology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Autophagy, cell death, and cytokines inEmerging microbes & infections · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Amanda J BrinkworthLaboratory of Human Bacterial Pathogens, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Disease, National Institute of Health, Hamilton, MT, United States of America.
Carl H HammerResearch Technologies Branch, National Institute of Allergy and Infectious Disease, National Institute of Health, Bethesda, MD, United States of America.
L Renee OlanoResearch Technologies Branch, National Institute of Allergy and Infectious Disease, National Institute of Health, Bethesda, MD, United States of America.
Scott D KobayashiLaboratory of Human Bacterial Pathogens, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Disease, National Institute of Health, Hamilton, MT, United States of America.
Liang ChenPublic Health Research Institute Tuberculosis Center, New Jersey Medical School, Rutgers the State University of New Jersey, Newark, NJ, United States of America.
Barry N KreiswirthPublic Health Research Institute Tuberculosis Center, New Jersey Medical School, Rutgers the State University of New Jersey, Newark, NJ, United States of America.
Frank R DeLeoLaboratory of Human Bacterial Pathogens, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Disease, National Institute of Health, Hamilton, MT, United States of America.
National Institute of Allergy and Infectious Diseases · USRutgers, The State University of New Jersey · US

Funding

Infectious Diseases Research Technologies Core - BethesdaZICAI001051 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI CHERRY, JAMES · 2009 to 2025
$226.1M
Basis for Success of Multidrug-Resistant EnterobacteriaceaeZIAAI001195 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DELEO, FRANK · 2014 to 2025
$11.9M
Intramural NIH HHS
6 · The paper itself

Abstract

Carbapenem-resistant Klebsiella pneumoniae strains have emerged as a cause of life-threatening infections in susceptible individuals (e.g., transplant recipients and critically ill patients). Strains classified as multilocus sequence type (ST) 258 are among the most prominent causes of carbapenem-resistant K. pneumoniae infections worldwide, but the basis for the success of this lineage remains incompletely determined. To gain a more comprehensive view of the molecules potentially involved in the success of ST258, we used a proteomics approach to identify surface-associated and culture supernatant proteins produced by ST258. Protein samples were prepared from varied culture conditions in vitro, and were analyzed by a combination of two-dimensional electrophoresis and liquid chromatography followed by tandem mass spectrometry (LC-MS/MS). We identified a total of 193 proteins in outer membrane preparations from bacteria cultured in Luria-Bertani broth (LB) or RPMI 1640 tissue culture media (RPMI). Compared with LB, several iron-acquisition proteins, including IutA, HmuR, HmuS, CirA, FepA, FitA, FoxA, FhuD, and YfeX, were more highly expressed in RPMI. Of the 177 proteins identified in spent media, only the fimbrial subunit, MrkA, was predicted to be extracellular, a finding that suggests few proteins (or a limited quantity) are freely secreted by ST258. Notably, we discovered 203 proteins not reported in previous K. pneumoniae proteome studies. In silico modeling of proteins with unknown function revealed several proteins with beta-barrel transmembrane structures typical of porins, as well as possible host-interacting proteins. Taken together, these findings contribute several new targets for the mechanistic study of drug-resistance and pathogenesis by ST258 K. pneumoniae isolates.

Indexed as

Bacterial Typing TechniquesMultilocus Sequence TypingBacterial Outer Membrane ProteinsCarbapenemsCulture MediaDrug Resistance, BacterialElectrophoresis, Gel, Two-DimensionalKlebsiella pneumoniaeMass SpectrometryBacterial Outer Membrane ProteinsCarbapenemsCulture Media

Identifiers

PMID25893665
PMCPMC4404324
OpenAlexW1969152624

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.